Laura Archer

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

Brian I. Rini, Susan Halabi, Jonathan E. Rosenberg et al. · Journal of Clinical Oncology · 2008 · 906 citations · Full text

Adherence and Persistence With Oral Adjuvant Chemotherapy in Older Women With Early-Stage Breast Cancer in CALGB 49907: Adherence Companion Study 60104

Ann H. Partridge, Laura Archer, Alice B. Kornblith et al. · Journal of Clinical Oncology · 2010 · 126 citations · Full text

Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer

Susan Halabi, Nicholas J. Vogelzang, San‐San Ou et al. · Journal of Clinical Oncology · 2009 · 111 citations · Full text

Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102)

Todd L. Demmy, Lin Gu, Jack E. Burkhalter et al. · Journal of the National Comprehensive Cancer Network · 2012 · 107 citations · Full text

Pneumothorax, Medicine, Pleural Effusion +14

Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809

Charles L. Shapiro, Susan Halabi, Vera Hárs et al. · European Journal of Cancer · 2011 · 100 citations

Calgb Trial 79809, Bone Disease, Zoledronic Acid +15